Which mouse strains do you routinely use for immunization?

We primarily use Balb/c and C57BL/6 strains for standard immunization protocols. For specialized projects, we also support immunization in alternative strains, rats, or even transgenic humanized mouse models based on your specific requirements.

What is the typical timeline from project initiation to delivery of positive clones?

Our standard delivery timeline is 3-6 months, depending on antigen immunogenicity and screening stringency. For time-critical projects, choosing to skip the immunization process and directly using our premade mouse antibody library for antibody development can reduce this timeline to 6 to 8 weeks.

How do you ensure that the final antibody recognizes the native conformation of my protein?

We incorporate both ELISA (for linear epitope detection) and FACS or cell-based ELISA (for native conformation epitopes) during the screening process. This dual approach ensures that the antibodies we deliver are validated to recognize your target in its biologically relevant, native state.

Will I receive the antibody gene sequences?

Absolutely. We provide complete variable region sequencing for all positive hybridoma clones and deliver the full sequence information to you upon project completion. This ensures that you maintain full intellectual property ownership and the ability to produce recombinant antibodies independently.

Can you generate antibodies against post-translational modifications or specific phosphorylation sites?

Yes. We employ modified peptide immunogens incorporating specific post-translational modifications and combine them with differential screening strategies to enrich for modification-specific antibodies while excluding those that recognize the unmodified sequence.

What quality control measures are applied to the delivered antibodies?

Every antibody undergoes rigorous characterization, including specificity testing (ELISA, Western blot, FACS), affinity measurement (SPR or ELISA-based), and cross-reactivity assessment against related antigens. A comprehensive Certificate of Analysis is provided with every delivery, documenting all characterization results.

Monoclonal Mouse Antibody Discovery Introduction

Overview Advantages Applications Our Platform Our Services FAQs

Monoclonal Mouse Antibody Discovery

Monoclonal mouse antibodies remain the gold-standard reagents for probing complex biological processes, validating therapeutic targets, and developing robust diagnostic tools. For over four decades, these exquisitely specific molecular probes have underpinned breakthroughs in immunology, oncology, and cell biology. Their proven reliability, well-characterized production platforms, and exceptional specificity make them indispensable for researchers who demand reproducibility, consistency, and experimental confidence.

Yet antibody discovery projects often encounter significant hurdles, including poor immunogenicity of conserved targets, high background from nonspecific binders, batch-to-batch variability that compromises reproducibility, and failure to recognize native protein conformations. These challenges can derail timelines and erode confidence in downstream data.

Fig.1 Antibody. (Creative Biolabs Authorized) At Creative Biolabs, we deliver monoclonal mouse antibody production services backed by decades of hybridoma and phage display expertise. Every antibody is characterized for specificity, affinity, and consistency, supported from target validation to functional studies.

Discuss Your Target-Specific Requirements with Our Scientific Team

Key Advantages

Optimized Immunization Strategies

We tailor each immunization protocol to your antigen's biochemical properties, whether protein, peptide, DNA, or cell-based. For challenging targets like GPCRs and ion channels, we employ specialized adjuvants, optimized dosing, and proprietary presentation techniques to break immune tolerance and elicit high-titer responses.

High-Throughput, High-Content Screening

Our automated platforms combine liquid handling with multiplexed detection including ELISA, FACS, and functional cell-based assays. Within weeks, we screen thousands of hybridoma clones to identify rare candidates with high-affinity binding and the precise functional activity you require.

Strict Specificity and Sequence Verification

We perform comprehensive cross-reactivity panels against related antigens and off-target proteins to eliminate nonspecific binding. Complete variable region sequencing for every lead antibody ensures unambiguous specificity, documented genetic identity, and predictable performance across experiments.

Flexible Downstream Support Services

Our support extends beyond discovery. We provide recombinant production in CHO or HEK293 systems, antibody engineering including chimerization, humanization, and Fc modification, conjugation to fluorophores or enzymes, and stable cell line generation. This integrated approach streamlines your workflow and eliminates the burden of coordinating multiple vendors.

Partner with Us to Overcome Your Antibody Discovery Challenges

Research Applications

The versatility of monoclonal mouse antibodies makes them invaluable tools across a broad spectrum of research applications:

Basic Science Research

As high-precision molecular probes, monoclonal mouse antibodies serve as cornerstones for investigating fundamental biological mechanisms. Their applications include:

Signaling pathway dissection: probing phosphorylation events and protein activation states
Cell typing and immunophenotyping: identifying and isolating specific cell populations via FACS
Tissue localization studies: visualizing protein expression patterns through IHC and immunofluorescence
Protein interaction mapping: capturing native complexes via Co-IP and ChIP assays
Quantitative protein detection: enabling sensitive and specific ELISA-based measurements

Translational Medicine and Diagnostics

Monoclonal mouse antibodies provide specificity and reproducibility essential for diagnostic development.:

Biomarker discovery and validation: providing reliable detection reagents for disease-associated proteins
Diagnostic kit development: serving as core capture or detection antibodies in ELISA and lateral flow formats
Companion diagnostics: enabling patient stratification and treatment monitoring
Proof-of-concept studies: validating therapeutic hypotheses in preclinical disease models

Drug Discovery and Development

In pharmaceutical R&D, monoclonal mouse antibodies play essential roles throughout the discovery pipeline:

Target validation: confirming the biological relevance of novel drug targets
Screening assay development: serving as positive controls or neutralizing reagents in high-throughput screens
Pharmacokinetic and pharmacodynamic studies: enabling detection and quantification of lead candidates in biological matrices
Mechanism of action studies: dissecting drug-target interactions and downstream signaling effects

Start Your Discovery Project with Confidence

Our Dual Platform: Hybridoma & Phage Display

No single antibody discovery platform can address every research challenge. That is precisely why Creative Biolabs offers two powerful, complementary technology engines. This dual-platform strategy ensures that your unique target receives the optimal discovery approach, maximizing the probability of generating the ideal antibody for your research needs.

Classic Hybridoma Technology

Fig.2 The workflow of mouse antibody discovery by hybridoma platform. (Creative Biolabs AI)

Our hybridoma platform harnesses the natural power of the mouse immune system to generate monoclonal antibodies with authentic heavy and light chain pairing. Following carefully designed immunization protocols, splenocytes are fused with immortalized myeloma cells, creating hybridomas that preserve the full functional diversity of the in vivo immune response. This approach is particularly well-suited for:

Generating antibodies that recognize native conformational epitopes
Projects requiring large quantities of functional antibody for downstream applications
Targets where preserving natural antigen presentation is critical

Phage Display Platform

For targets that present significant immunization challenges, such as highly conserved proteins, toxins, or self-antigens, our phage display platform offers a powerful alternative. By constructing immune libraries from immunized mice, we can rapidly screen billions of antibody variants displayed on phage particles. This approach enables:

Isolation of antibodies against targets that fail to elicit strong immune responses
Selection of antibodies with defined epitope specificity
Identification of high-affinity clones that may be inaccessible through conventional hybridoma approaches

By offering both platforms, Creative Biolabs empowers researchers to choose the path that best aligns with their specific experimental objectives, target characteristics, and timeline requirements.

Request a Consultation on Our Dual-Platform Technology

Our Services

Creative Biolabs provides comprehensive, end-to-end services spanning the entire antibody discovery and development continuum:

Custom Monoclonal Mouse Antibody Discovery

This complete package covers antigen preparation, tailored immunization, high-efficiency fusion, rigorous screening, and validated clone delivery. Every stage is customized to your antigen type, antibody requirements, and downstream applications, ensuring seamless integration into your research workflow.

Antibody Sequencing and Recombinant Production

Variable region sequencing ensures IP ownership and sequence transparency. High-yield recombinant production in CHO or HEK293 provides consistent, renewable supply for long-term research.

Get a Customized Quote for Your Mouse mAb Project

FAQs

Q: Which mouse strains do you routinely use for immunization?
A: We primarily use Balb/c and C57BL/6 strains for standard immunization protocols. For specialized projects, we also support immunization in alternative strains, rats, or even transgenic humanized mouse models based on your specific requirements.
Q: What is the typical timeline from project initiation to delivery of positive clones?
A: Our standard delivery timeline is 3-6 months, depending on antigen immunogenicity and screening stringency. For time-critical projects, choosing to skip the immunization process and directly using our premade mouse antibody library for antibody development can reduce this timeline to 6 to 8 weeks.
Q: How do you ensure that the final antibody recognizes the native conformation of my protein?
A: We incorporate both ELISA (for linear epitope detection) and FACS or cell-based ELISA (for native conformation epitopes) during the screening process. This dual approach ensures that the antibodies we deliver are validated to recognize your target in its biologically relevant, native state.
Q: Will I receive the antibody gene sequences?
A: Absolutely. We provide complete variable region sequencing for all positive hybridoma clones and deliver the full sequence information to you upon project completion. This ensures that you maintain full intellectual property ownership and the ability to produce recombinant antibodies independently.
Q: Can you generate antibodies against post-translational modifications or specific phosphorylation sites?
A: Yes. We employ modified peptide immunogens incorporating specific post-translational modifications and combine them with differential screening strategies to enrich for modification-specific antibodies while excluding those that recognize the unmodified sequence.
Q: What quality control measures are applied to the delivered antibodies?
A: Every antibody undergoes rigorous characterization, including specificity testing (ELISA, Western blot, FACS), affinity measurement (SPR or ELISA-based), and cross-reactivity assessment against related antigens. A comprehensive Certificate of Analysis is provided with every delivery, documenting all characterization results.

Transform Your Target into a Validated Research Tool Today

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: